Dr. Mahesan Subramaniam: How a 1972 Blood Sample Led to a Life-Saving Genetic Discovery
Dato Capt. Dr. Mahesan Subramaniam, Co-Founder United Health Tourism, shared a post on LinkedIn:
“A blood sample taken from a pregnant woman in 1972 lacked a surface molecule found on nearly all other red blood cells. Over fifty years later, researchers in the UK and Israel identified this anomaly as a new human blood group system, now called the MAL blood group. This discovery, published in 2024, sheds light on a rare but important blood variation that could help save lives.
Most people have an antigen called AnWj, which coats red blood cells. In the 1972 patient, this antigen was missing. The researchers found that when both copies of a person’s MAL gene carry a mutation, they do not produce the AnWj antigen, resulting in an AnWj-negative blood type. Some other patients lacked AnWj due to blood disorders that suppressed the antigen rather than a gene mutation.
The MAL protein is small but important, stabilizing cell membranes and helping transport materials inside cells. The antigen itself isn’t present at birth but develops shortly after. By inserting a normal MAL gene into AnWj-negative cells, scientists confirmed that this gene controls the presence of the antigen.
Research Paper
DOI: 10.1182/blood.2024025099”
Title: Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype
Authors: Louise A Tilley, Vanja Karamatic Crew, Tosti J Mankelow, Samah A AlSubhi, Benjamin Jones, Abigail Borowski, Vered Yahalom, Lilach Finkel, Belinda K Singleton, Piers J Walser, Ashley M Toye, Timothy J Satchwell, Nicole M Thornton

Read full article here.
Stay informed with Hemostasis Today.
-
Nov 14, 2026, 13:47Karen A. Moffat: New 2026 Issue on Laboratory Diagnostics in Thrombosis and Haemostasis
-
Nov 14, 2026, 13:45César Erazo: Investigating Anticoagulation in Secondary Stroke Prevention at AHA 2026
-
Nov 14, 2026, 13:41Hussein Abdelwahab: FDA Approves Asundexian as the First Factor XIa Inhibitor for Stroke Prevention
-
Nov 14, 2026, 13:31John Augoustides: Practical Anticoagulation Strategies for Cardiopulmonary Bypass in Patients with HIT
-
Nov 14, 2026, 13:09Antonio Galante: Management of Portal Vein Thrombosis
-
Nov 14, 2026, 12:47Yasmin Mohtasham Kia: Anticoagulation Knowledge and Treatment Outcomes in Patients With Mechanical Heart Valves
-
Nov 14, 2026, 12:37Nathan Connell: Annualized Bleeding Rate and the Future of Hemophilia A Treatment
-
Nov 14, 2026, 12:3210 Posts Not to Miss This Week
-
Nov 14, 2026, 11:28Kalyan Roy: A New Era in Thalassemia Treatment – FDA Approves Mitapivat